Day: January 15, 2024
Rising adoption of EDI, and rapid technological advancements in Healthcare EDI are key factors driving healthcare Electronic Data Interchange (EDI) market revenue growth.
Vancouver, Jan. 15, 2024 (GLOBE NEWSWIRE) — The global healthcare Electronic Data Interchange (EDI) market size was USD 4.56 Billion in 2022 and is expected to register a rapid revenue CAGR of 9.8% during the forecast period. Rising adoption of EDI, and rapid technological advancements in Healthcare EDI are key factors driving market revenue growth.
A key trend in the market is rapid technological advancements in the healthcare EDI. Among the most significant advancements in healthcare EDI market over the past year is the development of bio-Cloud based EDI solution. This is a significant development because it helps to improve the efficiency and interoperability...
Correction: Hermès International: Shares and voting rights as of 31st December 2023
Written by Customer Service on . Posted in Public Companies.
RELEASE
Paris, January 15, 2024
INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES COMPRISING THE SHARE CAPITALIn accordance with the provisions of Article L. 233-8 of the French Commercial Code (Code de commerce) and Article 223-16 of the General Regulations of French Autorité des Marchés Financiers (AMF), Hermès international publishes each month, before the 15th day of the following month, the total number of voting rights and the number of shares comprising the share capital if they have varied from those previously published.Date
Total number of shares
Total number of theoretical voting rights (including treasury stock)
Total number of effective voting rights (exercisable at shareholders’ meetings)
Publications31 December 2023
105 569 412
179 317 667 1
178 478 552 1
15 January 2024...
Ipsos acquires Jarmany, a company specialising in data management and analytics in the UK
Written by Customer Service on . Posted in Mergers And Acquisitions.
Ipsos acquires Jarmany, a company specialising in data management and analytics in the UK
Paris, January 15th, 2024 – Ipsos, one of the world’s leading market research companies, announces the acquisition of Jarmany, a company renowned for its expertise in data analytics and strategy in the UK.
Founded in 2008, Jarmany supports a range of international companies in their operational, financial and strategic decision-making. Its expertise is grounded in the aggregation, analysis and visualisation of data, in particular through the use of artificial intelligence.
The company will continue to be led by its co-founders, Matthew Rhodes and Tom Hunt. The Jarmany team joins the Ipsos business in the UK, with whom they will work closely to develop their capabilities in integrating diverse and complex datasets.
Ben Page, Chief Executive...
Boussard & Gavaudan Holding Ltd (EUR): Newsletter December 2023
Written by Customer Service on . Posted in Public Companies.
Good evening,
Please find enclosed BGHL December 2023 Newsletter.
Best regards, Enquiries:
Boussard & Gavaudan Investment Management, LLP Email: info@bgam-uk.com
This document is issued by Boussard & Gavaudan Investment Management, LLP. which is authorised and regulated in the conduct of investment business by the Financial Conduct Authority in the United Kingdom. This document is for information purposes only and is not an offer to invest. Boussard & Gavaudan Holding Limited is a closed-ended investment company incorporated under the laws of Guernsey. Boussard & Gavaudan Holding Limited is registered with the Dutch Authority for Financial Markets as a collective investment scheme under article 1.107 of the Dutch Financial Markets Supervision Act. All investment is subject to risk. Past performance is no guarantee...
Voltalia SA:Total number of shares and voting rights in the share capital as of December 31, 2023
Written by Customer Service on . Posted in Public Companies.
Total number of shares and voting rights in the share capital as of December 31, 2023 (Articles L. 233-8 (II) of the French Commercial Code and 223-16 of the General Regulations of the French Financial Markets Authority) Date
Total number of shares in the capital
Number of theoretical voting rights
Number of exercisable voting rights 12/31/2023
131 318 716
197 646 226
197 278 926Next on the agenda: Q4 2023 Turnover, on January 31, 2024 (after market close)About Voltalia (www.voltalia.com)Voltalia is an international player in the renewable energy sector. The Group produces and sells electricity generated from wind, solar, hydraulic, biomass and storage facilities that it owns and operates. Voltalia has generating capacity in operation and under construction of more than 2.8 GW and a portfolio of projects...
Boussard & Gavaudan Holding Ltd (GBP): Newsletter December 2023
Written by Customer Service on . Posted in Public Companies.
Good evening,
Please find enclosed BGHL December 2023 Newsletter.
Best regards, Enquiries:
Boussard & Gavaudan Investment Management, LLP Email: info@bgam-uk.com
This document is issued by Boussard & Gavaudan Investment Management, LLP. which is authorised and regulated in the conduct of investment business by the Financial Conduct Authority in the United Kingdom. This document is for information purposes only and is not an offer to invest. Boussard & Gavaudan Holding Limited is a closed-ended investment company incorporated under the laws of Guernsey. Boussard & Gavaudan Holding Limited is registered with the Dutch Authority for Financial Markets as a collective investment scheme under article 1.107 of the Dutch Financial Markets Supervision Act. All investment is subject to risk. Past performance is no guarantee...
Guerbet: Financial agenda for 2024
Written by Customer Service on . Posted in Public Companies.
Financial agenda for 2024
Villepinte, 15 January 2024: Guerbet (FR0000032526), a global specialist in contrast agents and solutions for medical imaging, is announcing its financial agenda for 2024.Publications calendar2023 ANNUAL REVENUEFebruary 08, 2024, after trading2023 ANNUAL RESULTSMarch 20, 2024, after trading2024 1ST QUARTER REVENUEApril 25, 2024, after tradingANNUAL SHAREHOLDERS’ MEETINGMay 24, 20242024 2ND QUARTER REVENUEJuly 25, 2024, after trading2024 FIRST HALF RESULTSSeptember 25, 2024, after trading2024 3RD QUARTER REVENUEOctober 24, 2024, after trading
About Guerbet
At Guerbet, we build lasting relationships so that we enable people to live better. That is our purpose. We are a leader in medical imaging worldwide, offering a comprehensive range of pharmaceutical...
Urinary Drainage Bags Market Size Worth USD 2.84 Billion in 2032 | Emergen Research
Written by Customer Service on . Posted in Mergers And Acquisitions.
Rising elderly population, and increase in gynaecological and urological operations are some of the key factors driving Urinary Drainage Bags market revenue growth.
Vancouver, Jan. 15, 2024 (GLOBE NEWSWIRE) — The global urinary drainage bags market size was USD 1.99 Billion in 2022 and is expected to register a revenue CAGR of 3.7% during the forecast period. Increasing prevalence of urological disorders, rising elderly population, and increase in gynaecological and urological operations are some of the key factors driving market revenue growth.
Moreover, rising number of urinary infections is one the key factors driving revenue growth of the market. Urinary Tract Infections (UTIs) stand as one of the prevalent bacterial infections encountered in clinical settings. Their primary impact lies within the lower urinary tract, specifically...
Kojamo Plc: Kojamo increases bond maturing in 2029 by EUR 200 million as a private placement
Written by Customer Service on . Posted in Public Companies.
Kojamo plc Stock Exchange Release, 15 January 2024 at 7:15 p.m EET
Kojamo increases bond maturing in 2029 by EUR 200 million as a private placement
On 22 January 2024, Kojamo plc will issue EUR 200 million unsecured green notes as a private placement. The new notes are issued under the company’s EMTN programme as an increase to the company’s notes maturing on 28 May 2029 (ISIN XS2345877497). The issue price of the new notes is 77.848%. The proceeds of the issue will be used for the refinancing of projects in accordance with the company’s Green Finance Framework.
“This is the first sizable euro-denominated bond issuance by a residential real estate company since 2022. We are very pleased to see the investors’ strong interest in the company, and this shows our access to diverse sources of funding,” says CFO Erik Hjelt.
OP Corporate Bank...
AB Science receives notice of allowance for European patent covering masitinib until 2036 in the treatment of mastocytosis
Written by Customer Service on . Posted in Public Companies.
PRESS RELEASE
AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN PATENT COVERING MASITINIB UNTIL 2036 IN THE TREATMENT OF MASTOCYTOSIS
THIS DECISION FURTHER STRENGTHENS MASITINIB’S INTELLECTUAL PROPERTY PROTECTION STRATEGY BASED ON MEDICAL USE PATENTS
Paris, January 15, 2024, 6pm CET
AB Science SA (Euronext – FR0010557264 – AB) today announced that the European Patent Office has issued a Notice of Allowance for a patent relating to methods of treating severe systemic mastocytosis (i.e. a medical use patent) with its lead compound masitinib, based on findings from study AB06006 [1]. This new European patent provides intellectual property protection for masitinib in this indication until October 2036.
The same medical use patent strategy had been successfully pursued in amyotrophic lateral sclerosis, with patent granted worldwide...